Date updated:05-04-2007
From 10Q Detective
"In 2006, scientists fervently working on a treatment for H5N1, or bird flu, fearful that infected humans in China might be the start of a possible pandemic. This interest in experimental drugs and vaccines drew investors to any biotech stock that was remotely doing anything avian-related in nature. Sadly, like Tulipomania, dot-coms, and nanotechnology stocks, investors who ro! lled the dice on bird flu stocks—for the most part—have lost."
These are a few companies that may pay off big if the bird flue epidemic ever becomes a serious worldwide problem.

-
ENDP
Endo Pharmaceutic - $23.00
- +0.48%
- $22.69
Symmetrel, FDA-approved to treat influenza A*

-
CARN
Carn - $0.00
- N/A
- $N/A
Rec'd $6M grant from U.S. to develop H5N1 vaccine

-
DVAX
Dynavax Technolog - $1.28
- +4.92%
- $1.22
Imunostimulatory sequence technology to target virus

-
VICL
Vical Incorporate - $3.06
- +0.33%
- $3.04
Developing DNA-based vaccine vs. H5N1

-
AVAN
Avan - $0.00
- N/A
- $N/A
Announced plans to research H5N1 vaccine

-
AVII
Avi Biopharma - $1.44
- -3.36%
- $1.46
Antisense-based therapeutic

-
CRXL
Crucell Nv - $21.18
- 0.00%
- $21.00
PER.C6 tech used by Sanofi in H5N1 vaccine development

-
HEB
Hemispherx Biopha - $1.22
- -2.40%
- $1.25
Alferon, stimulates Interferon to defend vs. H5N1
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. WisdomTree Intl Consum...
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. i bought into ECLP last thursday. . They
compete with CERNER on putting in big
medical records systems into hospitals.
I believe the industry is going to
consolidate as well.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the largest % gainers from Nov. 2, 2009. more
Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more
These are the stocks from Jim Cramer's Oct. 30 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more













Comments not available